Healthcare Leaders Income Fund

HHL-T

Analysis and Opinions about HHL-T

Signal
Opinion
Expert
Chart
BUY
BUY
May 3, 2021
For income in retirement account. Would prefer ZWU to HHL. If markets correct over the next few quarters, there will be more correction in HHL. Likes both and are both buys in pull backs.
Show full opinionHide full opinion
For income in retirement account. Would prefer ZWU to HHL. If markets correct over the next few quarters, there will be more correction in HHL. Likes both and are both buys in pull backs.
BUY
BUY
May 3, 2021
For income in retirement account. Would prefer ZWU to HHL. If markets correct over the next few quarters, there will be more correction in HHL. Likes both and are both buys in pull backs.
Show full opinionHide full opinion
For income in retirement account. Would prefer ZWU to HHL. If markets correct over the next few quarters, there will be more correction in HHL. Likes both and are both buys in pull backs.
BUY
BUY
March 15, 2021

HHL-T & XHC-T. HHL-T has a high yield because they do covered calls. He prefers the XHC-T ETF for slightly more yield. HHL-T is a viable option but you are capping the upside.

Show full opinionHide full opinion

HHL-T & XHC-T. HHL-T has a high yield because they do covered calls. He prefers the XHC-T ETF for slightly more yield. HHL-T is a viable option but you are capping the upside.

Mike Philbrick
Price
$7.800
Owned
Unknown
BUY
BUY
March 8, 2021
Overall, as society ages, healthcare will become a more important part. The cost of healthcare will cause government pushback on big pharma. It is a growth area. Healthcare technology will be a big part of growth. There is the underlying dividends and covered calls.
Show full opinionHide full opinion
Overall, as society ages, healthcare will become a more important part. The cost of healthcare will cause government pushback on big pharma. It is a growth area. Healthcare technology will be a big part of growth. There is the underlying dividends and covered calls.
COMMENT
COMMENT
February 11, 2021
Comment on the change from ROC to capital gains on fund distribution. Bulk of distribution is generated through covered calls, which are taxed as capital gains. Still a tax efficient distribution. HHL.A is currency hedged, while the HHL.U is priced in US dollars.
Show full opinionHide full opinion
Comment on the change from ROC to capital gains on fund distribution. Bulk of distribution is generated through covered calls, which are taxed as capital gains. Still a tax efficient distribution. HHL.A is currency hedged, while the HHL.U is priced in US dollars.
Paul MacDonald
Price
$7.810
Owned
Yes
COMMENT
COMMENT
February 1, 2021

They use a covered call strategy to enhance the yield. Those who want exposure to healthcare space but want higher yield, it is a good option. If yield is not a concern for you, you're better off with ZUH.

Show full opinionHide full opinion

They use a covered call strategy to enhance the yield. Those who want exposure to healthcare space but want higher yield, it is a good option. If yield is not a concern for you, you're better off with ZUH.

BUY
BUY
November 9, 2020
A broad based actively managed healthcare company fund. They screen fundamentally for better names in the healthcare space with covered calls for extra yield. A good yield play with less market volatility.
Show full opinionHide full opinion
A broad based actively managed healthcare company fund. They screen fundamentally for better names in the healthcare space with covered calls for extra yield. A good yield play with less market volatility.
BUY
BUY
October 20, 2020

Disclosure: He runs this ETF, 20 equally-weighted large US healthcare stocks. He makes minor adjustments periodically, like selling Gilead recently. He wants diversification across this space. Pays a high dividend, using covered calls for a third of the holdings. This is good if you want US healthcare and regular income with some appreciation.

Show full opinionHide full opinion

Disclosure: He runs this ETF, 20 equally-weighted large US healthcare stocks. He makes minor adjustments periodically, like selling Gilead recently. He wants diversification across this space. Pays a high dividend, using covered calls for a third of the holdings. This is good if you want US healthcare and regular income with some appreciation.

Paul MacDonald
Price
$7.570
Owned
Yes
BUY
BUY
October 19, 2020
A managed strategy that is designed to produce high yield through options and other strategy. There are elements of growth but the price has stayed consistent. The dividend has stayed north of 7%. You're investing for the yield and to get exposure to healthcare.
Show full opinionHide full opinion
A managed strategy that is designed to produce high yield through options and other strategy. There are elements of growth but the price has stayed consistent. The dividend has stayed north of 7%. You're investing for the yield and to get exposure to healthcare.
COMMENT
COMMENT
September 17, 2020
Attractive income, equal weighted 20 largest healthcare companies. Covered calls on a portion of the portfolio. Secularly, has some solid fundamentals of increased spending in drug sales and healthcare. Suspects the 9% yield is not sustainable with low interest rates.
Show full opinionHide full opinion
Attractive income, equal weighted 20 largest healthcare companies. Covered calls on a portion of the portfolio. Secularly, has some solid fundamentals of increased spending in drug sales and healthcare. Suspects the 9% yield is not sustainable with low interest rates.
Mike Philbrick
Price
$7.750
Owned
Unknown
COMMENT
COMMENT
September 14, 2020
These are some of the best ETFs for playing healthcare depending on what strategy you like. These cover global, covered call, yield focused, or actively managed ETFs in the market. The sector is a little overvalued right now so you might want to wait for a pullback. Longterm outlook is favourable.
Show full opinionHide full opinion
These are some of the best ETFs for playing healthcare depending on what strategy you like. These cover global, covered call, yield focused, or actively managed ETFs in the market. The sector is a little overvalued right now so you might want to wait for a pullback. Longterm outlook is favourable.
BUY
BUY
July 31, 2020
This covers mature companies, covered calls, and yield generators. In the next couple decades, as societies age across the world, healthcare will be a good trend. It is a good long term play.
Show full opinionHide full opinion
This covers mature companies, covered calls, and yield generators. In the next couple decades, as societies age across the world, healthcare will be a good trend. It is a good long term play.
BUY
BUY
July 20, 2020

LIFE vs. HHL In Canada, we have two similar ETFs holding global healthcare, this and HHL-T. Each holds around 20 megacap stocks, equally weighted. He prefers LIFE because the names it holds are more diverse, but owning either or both is fine. Both feature a covered call a third of their portfolios, which is good, because you want two-thirds to really capture the upside potential in this thriving sector. Who knows which set of stocks within these ETFs will hit? You could own both. Plus, you get a little income.

Show full opinionHide full opinion

LIFE vs. HHL In Canada, we have two similar ETFs holding global healthcare, this and HHL-T. Each holds around 20 megacap stocks, equally weighted. He prefers LIFE because the names it holds are more diverse, but owning either or both is fine. Both feature a covered call a third of their portfolios, which is good, because you want two-thirds to really capture the upside potential in this thriving sector. Who knows which set of stocks within these ETFs will hit? You could own both. Plus, you get a little income.

Mike Philbrick
Price
$7.790
Owned
Unknown
BUY
BUY
July 17, 2020

Made up of the 20 leading pharma companies. He likes this strategy. It's similar to LIFE-T though there are some differences. The healthcare space is in good shape for growth for years to come. A good growth enhancement name.

Show full opinionHide full opinion

Made up of the 20 leading pharma companies. He likes this strategy. It's similar to LIFE-T though there are some differences. The healthcare space is in good shape for growth for years to come. A good growth enhancement name.

BUY
BUY
June 12, 2020

He likes the strategy. Healthcare with options strategies to enhance yield. LIFE-T is also an interesting way to play healthcare. Healthcare should be a growth area over the next few years although a change in government in the US could represent some risk.

Show full opinionHide full opinion

He likes the strategy. Healthcare with options strategies to enhance yield. LIFE-T is also an interesting way to play healthcare. Healthcare should be a growth area over the next few years although a change in government in the US could represent some risk.

Showing 1 to 15 of 55 entries

Healthcare Leaders Income Fund(HHL-T) Rating

Ranking : 5 out of 5

Bullish - Buy Signals / Votes : 13

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 13

Stockchase rating for Healthcare Leaders Income Fund is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Healthcare Leaders Income Fund(HHL-T) Frequently Asked Questions

What is Healthcare Leaders Income Fund stock symbol?

Healthcare Leaders Income Fund is a Canadian stock, trading under the symbol HHL-T on the Toronto Stock Exchange (HHL-CT). It is usually referred to as TSX:HHL or HHL-T

Is Healthcare Leaders Income Fund a buy or a sell?

In the last year, 13 stock analysts published opinions about HHL-T. 13 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is BUY. Read the latest stock experts' ratings for Healthcare Leaders Income Fund.

Is Healthcare Leaders Income Fund a good investment or a top pick?

Healthcare Leaders Income Fund was recommended as a Top Pick by Larry Berman CFA, CMT, CTA on 2021-05-03. Read the latest stock experts ratings for Healthcare Leaders Income Fund.

Why is Healthcare Leaders Income Fund stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Healthcare Leaders Income Fund worth watching?

13 stock analysts on Stockchase covered Healthcare Leaders Income Fund In the last year. It is a trending stock that is worth watching.

What is Healthcare Leaders Income Fund stock price?

On 2021-05-14, Healthcare Leaders Income Fund (HHL-T) stock closed at a price of $8.26.